%20CO.%2C%20LTD./other/CHANGCHUN_HIGH-TECH_INDUSTRY_GROUP__inq51an.png)
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 董事会提名委员会工作细则(2020年3月) | 2020-03-26 | Chinese | |
| 2019年年度报告摘要 | 2020-03-26 | Chinese | |
| 关于2019年度利润分配及资本公积金转增股本预案的公告 | 2020-03-26 | Chinese | |
| 2019年年度报告 | 2020-03-26 | Chinese | |
| 2019年年度财务报告 | 2020-03-26 | Chinese | |
| 中信建投证券股份有限公司、中天国富证券有限公司关于公司发行股份及可转换债券购买资产并募集配套资金暨关联交易之2019年度募集资金存放与使用的专项核查报告 | 2020-03-26 | Chinese |
Browse filings by year
27 years- 2026 57 filings
- 2025 176 filings
- 2024 162 filings
- 2023 131 filings
- 2022 139 filings
- 2021 152 filings
- 2020 157 filings
- 2019 238 filings
- 2018 124 filings
- 2017 95 filings
- 2016 102 filings
- 2015 122 filings
- 2014 98 filings
- 2013 75 filings
- 2012 80 filings
- 2011 46 filings
- 2010 57 filings
- 2009 47 filings
- 2008 33 filings
- 2007 42 filings
- 2006 48 filings
- 2005 26 filings
- 2004 29 filings
- 2003 27 filings
- 2002 17 filings
- 2001 7 filings
- 1996 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 42949602 | 董事会提名委员会工作细则(2020年3月) | 2020-03-26 | Chinese | ||
| 42949579 | 2019年年度报告摘要 | 2020-03-26 | Chinese | ||
| 42949542 | 关于2019年度利润分配及资本公积金转增股本预案的公告 | 2020-03-26 | Chinese | ||
| 42949514 | 2019年年度报告 | 2020-03-26 | Chinese | ||
| 42949274 | 2019年年度财务报告 | 2020-03-26 | Chinese | ||
| 42948903 | 中信建投证券股份有限公司、中天国富证券有限公司关于公司发行股份及可转换债券购买资产并募集配套资金暨关联交易之2019年度募集资金存放与使用的专项核查报告 | 2020-03-26 | Chinese | ||
| 42948870 | 业绩承诺完成情况审核报告 | 2020-03-26 | Chinese | ||
| 42948831 | 募集资金存放与实际使用情况审核报告 | 2020-03-26 | Chinese | ||
| 42948802 | 独立董事关于第九届董事会第二十次会议审议相关事项的独立意见 | 2020-03-26 | Chinese | ||
| 42948771 | 关于会计政策变更的公告 | 2020-03-26 | Chinese | ||
| 42948594 | 关联交易管理制度(2020年3月) | 2020-03-26 | Chinese | ||
| 42948558 | 2019年度社会责任报告 | 2020-03-26 | Chinese | ||
| 42948533 | 控股股东及其他关联方占用资金情况审核报告 | 2020-03-26 | Chinese | ||
| 42948495 | 第九届监事会第十五次会议决议公告 | 2020-03-26 | Chinese | ||
| 42948463 | 关于召开2019年年度股东大会的通知 | 2020-03-26 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53737/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53737 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53737 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53737 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53737}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. (id: 53737)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.